Cardiology Update

JANUARY 2, 2024

Important Deadlines: 12 Feb ruary 2024 : Late-breaking science submissions 27 Feb ruary 2024 : Early Registration Savings 26 Mar 2024 : Late registration savings Fees: Visit the ESC Preventive Cardiology 2024 website for registration options. Hashtag: #ESCPrev2024 5. Hashtag: #HeartFailure2024 6.

Heart Failure 111

Heart Failure Atherosclerosis Cardiovascular Imaging Non-Invasive Cardiology 111

Cardiology Update

DECEMBER 3, 2023

Chadi Alraies discusses highlights from the American Heart Association (AHA) Scientific Sessions 2023, which were held in Philadelphia, Pennsylvania (PA), on November 11-13, 2023. There were many important developments in presented in key clinical trial presentations and publications stemming from the AHA Scientific Sessions 2023.

Research 98

Research Cardio Oncology COVID-19 Heart Failure 98

Cardiology Update

APRIL 9, 2024

Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardial infarction (MI).

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52